Early Response Monitoring of Receptor Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma Using [F-18]Fluorothymidine-Positron Emission Tomography-Magnetic Resonance

Early Response Monitoring of Receptor Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma Using [F-18]Fluorothymidine-Positron Emission Tomography-Magnetic Resonance

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Seminars in Roentgenology - Volume 49, Issue 3, July 2014, Pages 238-241

Laia MD, Christopher MD, Andrew MD, Lingzhi PhD, Zhenghong PhD, Raymond PhD, Norbert MD,